webcast resource

Presenter: M. Henry-Amar

Michel Henry-Amar, MD, PhD, is the Director of the “Cancéropôle Nord-Ouest Data Processing Centre (DPC)” at comprehensive cancer centre François Baclesse in Caen, France, and a member of the EORTC since 1970. Dr Henry-Amar’s research interests include the treatment of Hodgkin lymphoma in adults, cancer epidemiology, and study of long term complications of cancer treatments and their impact on patient rehabilitation and quality of life.
Dr. Henry-Amar received his undergraduate degree in basic sciences from Paris VI University, his medical degree from Paris XI University, and his PhD degree from Caen-Basse Normandie University. He completed training in epidemiology and biostatistics at INSERM (the French National Institute for Health and Medical Research).
Within the EORTC Lymphoma Group, Dr. Henry-Amar was in charge (data management and statistical analysis) of all phase III trials on Hodgkin lymphoma until 2004. He was behind the close collaboration between the French Groupe d’Études des Lymphomes de l’Adulte (GELA) and the EORTC Lymphoma Group which resulted in large inter-group trials. Dr. Henry-Amar participated in the development and validation of a scoring system based on prognostic factors, continuously applied in the design of trials conducted in early stages of the disease since 1988. He initiated translational research studies in pathology, prognostic studies on treatment efficacy and surveys in clinical epidemiology focusing on treatment induced complications (in particular second malignancies, sterility and persistent fatigue), quality of life and rehabilitation in long term survivors of Hodgkin lymphoma, and survival.
Dr. Henry-Amar has published 191 original papers in international peer-reviewed journals. He is the author or co-author of 36 published books and 385 abstracts. He received the Junior Investigation Award of the American College of Radiology (1986) and the Biarritz Prize of the French National League Against Cancer (1992)